FDA greenlights first drug-eluting stent in more than three years

HealthImaging.com, February 19, 2008
The Food and Drug Administration has approved Medtronic's Endeavor zotarolimus-eluting coronary stent system to be used in the treatment of coronary artery disease. It is the first new drug-eluting stent to be approved by the FDA since 2004.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.